Alzheimer's Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For patients and their caregivers:

• The patient has been diagnosed with both mild cognitive impairment or Alzheimer's disease/related dementia, and diabetes
• The patient currently has active prescriptions for diabetes treatment
• The patient has attended at least one appointment at an Eskenazi or IU Health primary care clinic within the past 12 months
• If the patient is unable to consent for themselves, they must be able to give assent and have a legally authorised representative who can consent on their behalf
• The patient has a caregiver who is 18 years of age or older and spends time with the patient every day, or nearly every day
• Both the patient and caregiver speak English
• Both the patient and caregiver live in the community (not in a care facility)
• The patient and caregiver have access to the internet

For healthcare providers (a separate part of the trial):

• Eligible clinician types include primary care doctors, nurses, pharmacists, nutritionists, psychologists, and medical residents

Who may not be able to join:

For patients and their caregivers:

• The patient has a terminal illness
• The patient uses an automated insulin delivery system
• The patient is currently receiving dialysis
• The patient is taking vitamin C (ascorbic acid) during the monitoring period
• The patient has an implanted medical device
• The patient has a bleeding disorder
• The patient has existing skin lesions on their arms
• The patient has an allergy to medical adhesive or isopropyl alcohol
• The patient has plans to undergo imaging or diathermy (a type of heat-based therapy) during the study period

For healthcare providers:

• Clinicians who only treat patients under the age of 65
• Clinicians who are not involved in managing patients' diabetes

Important: Always verify eligibility with the trial site directly before applying.